Noncanonical transforming growth factor β (TGFβ) signaling in cranial neural crest cells causes tongue muscle developmental defects

J Biol Chem. 2013 Oct 11;288(41):29760-70. doi: 10.1074/jbc.M113.493551. Epub 2013 Aug 15.

Abstract

Microglossia is a congenital birth defect in humans and adversely impacts quality of life. In vertebrates, tongue muscle derives from the cranial mesoderm, whereas tendons and connective tissues in the craniofacial region originate from cranial neural crest (CNC) cells. Loss of transforming growth factor β (TGFβ) type II receptor in CNC cells in mice (Tgfbr2(fl/fl);Wnt1-Cre) causes microglossia due to a failure of cell-cell communication between cranial mesoderm and CNC cells during tongue development. However, it is still unclear how TGFβ signaling in CNC cells regulates the fate of mesoderm-derived myoblasts during tongue development. Here we show that activation of the cytoplasmic and nuclear tyrosine kinase 1 (ABL1) cascade in Tgfbr2(fl/fl);Wnt1-Cre mice results in a failure of CNC-derived cell differentiation followed by a disruption of TGFβ-mediated induction of growth factors and reduction of myogenic cell proliferation and differentiation activities. Among the affected growth factors, the addition of fibroblast growth factor 4 (FGF4) and neutralizing antibody for follistatin (FST; an antagonist of bone morphogenetic protein (BMP)) could most efficiently restore cell proliferation, differentiation, and organization of muscle cells in the tongue of Tgfbr2(fl/fl);Wnt1-Cre mice. Thus, our data indicate that CNC-derived fibroblasts regulate the fate of mesoderm-derived myoblasts through TGFβ-mediated regulation of FGF and BMP signaling during tongue development.

Keywords: Craniofacial Development; Development; Mouse; Muscle; Tone; Transforming Growth Factor beta (TGFbeta).

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Animals
  • Cell Proliferation / drug effects
  • Cells, Cultured
  • Female
  • Fibroblast Growth Factor 4 / genetics
  • Fibroblast Growth Factor 4 / metabolism
  • Fibroblast Growth Factor 4 / pharmacology
  • Follistatin / genetics
  • Follistatin / metabolism
  • Follistatin / pharmacology
  • Gene Expression Profiling
  • Gene Expression Regulation, Developmental
  • Humans
  • Immunoblotting
  • Male
  • Mesenchymal Stem Cells / drug effects
  • Mesenchymal Stem Cells / metabolism
  • Mice
  • Mice, Knockout
  • Muscles / embryology
  • Muscles / metabolism*
  • Neural Crest / cytology
  • Neural Crest / embryology
  • Neural Crest / metabolism*
  • Protein Serine-Threonine Kinases / genetics*
  • Protein Serine-Threonine Kinases / metabolism
  • Proto-Oncogene Proteins c-abl / genetics
  • Proto-Oncogene Proteins c-abl / metabolism
  • Receptor, Transforming Growth Factor-beta Type II
  • Receptors, Transforming Growth Factor beta / genetics*
  • Receptors, Transforming Growth Factor beta / metabolism
  • Reverse Transcriptase Polymerase Chain Reaction
  • Signal Transduction / drug effects
  • Signal Transduction / genetics
  • Skull / embryology
  • Skull / metabolism
  • Tongue / cytology
  • Tongue / embryology
  • Tongue / metabolism*
  • Transforming Growth Factor beta / pharmacology

Substances

  • Fgf4 protein, mouse
  • Fibroblast Growth Factor 4
  • Follistatin
  • Receptors, Transforming Growth Factor beta
  • Transforming Growth Factor beta
  • Proto-Oncogene Proteins c-abl
  • Protein Serine-Threonine Kinases
  • Receptor, Transforming Growth Factor-beta Type II

Associated data

  • GEO/GSE45968